DOSSIER · 13F-HR · Q2 2026

Trails Edge Capital Partners, LP

$630M in tracked AUM across 35 positions as of Q2 2026.

TE
CIK 0002077247 · last filed Jun 30, 2026
Total AUM
$630M
as of Q2 2026
Holdings
35
positions
Whale Score
60
60
tracked
Activity
no data
changes this Q
AI Analysis · Q2 2026

Trails Edge Capital Partners, LP filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
LBRX
LB PHARMACEUTICALS INC
$49M1.5M7.8%
02
NRIX
NURIX THERAPEUTICS INC
$38M1.6M6.1%
03
IMCR
IMMUNOCORE HLDGS PLC
$34M1.1M5.4%
04
TRAX
FIRST TRACKS BIOTHERAPEUTICS
$30M1.5M4.8%
05
FDMT
4D MOLECULAR THERAPEUTICS IN
$30M2.2M4.7%
06
BMRN
BIOMARIN PHARMACEUTICAL INC
$29M512K4.7%
07
DSGN
DESIGN THERAPEUTICS INC
$29M2.0M4.6%
08
XENE
XENON PHARMACEUTICALS INC
$27M440K4.2%
09
MIRM
MIRUM PHARMACEUTICALS INC
$26M223K4.2%
10
INSM
INSMED INC
$25M230K3.9%

Filing history

2026Q2Jun 30
$630M 55.6%
35 positionsView →
2025Q4Dec 31
$405M
23 positionsView →